We adopted Bayesian analysis in combination with hierarchical (population) modelling to estimate simultaneously population and individual insulin sensitivity (S I ) and glucose effectiveness (S G ) with the minimal model of glucose kinetics using data collected during insulin-modified intravenous glucose tolerance test (IVGTT) and made comparison with the standard non-linear regression analysis. After fasting overnight, subjects with newly presenting Type II diabetes according to World Health Organization criteria (n = 65; 53 males, 12 females; age, 54 + − 9 years; body mass index, 30.4 + − 5.2 kg/m 2 ; means + − S.D.) underwent IVGTT consisting of a 0.3 g of glucose bolus/kg of body weight given at time zero for 2 min, followed by 0.05 unit of insulin/kg of body weight at 20 min. Bayesian inference was carried out using vague prior distributions and log-normal distributions to guarantee non-negativity and, thus, physiological plausibility of model parameters and associated credible intervals. Bayesian analysis gave estimates of S I in all subjects. Non-linear regression analysis failed in four cases, where Bayesian analysis-derived S I was located in the lower quartile and was estimated with lower precision. The population means of S I and S G provided by Bayesian analysis and non-linear regression were identical, but the interquartile range given by Bayesian analysis was tighter by approx. 20 % for S I and by approx. 15 % for S G . Individual insulin sensitivities estimated by the two methods were highly correlated (r S = 0.98; P < 0.001). However, the correlation in the lower 20 % centile of the insulin-sensitivity range was significantly lower than the correlation in the upper 80 % centile (r S = 0.71 compared with r S = 0.99; P < 0.001). We conclude that the Bayesian hierarchical analysis is an appealing method to estimate S I and S G , as it avoids parameter estimation failures, and should be considered when investigating insulin-resistant subjects.
INTRODUCTION
The minimal model analysis of intravenous glucose tolerance test (IVGTT) data has become an invaluable method to estimate insulin sensitivity (S I ) and glucose effectiveness (S G ). The analysis has been used in both smalland large-scale studies, such as the Insulin Resistance is too low. Nevertheless, it has been documented [3] that the minimal model fails in up to 50 % of cases in highly insulin-resistant subjects, although, with insulin modification and careful data analysis, the failure rate is normally approx. 10 %. Godsland and Walton [4] reported even higher failure rates with a high-glucose dose (0.5 g/kg), but without modification, and showed the importance of basal glucose levels to improve the success rate.
The standard minimal model data analysis employs the non-linear regression technique to obtain estimates of S I and S G [5] . Alternative calculation techniques have become available recently, specifically the Bayesian analysis with the so-called Markov chain Monte Carlo computational strategies [6] . These have been adopted to estimate S I and S G by analysing data on an individual basis [7, 8] , with the aim of reducing minimal model failures and providing physiologically plausible confidence intervals [CIs; credible intervals (CrIs) within the context of Bayesian analysis] of the estimates.
Recently, a population-based approach [9] , an iterative two-stage technique, has been investigated with reduced sampling and has been shown to improve precision compared with the standard non-linear regression approach. The strength of the population-based estimation techniques is that the knowledge about the underlying population distribution (usually normal or log-normal) can be employed in the estimation process, bringing about an improvement in the estimates of population and individual characteristics.
The present study extends these recent advances and reports on a Bayesian hierarchical analysis of the minimal model data. The combination of Bayesian methodology and hierarchical analysis (see Appendix for comments on Bayesian and hierarchical analyses) promises to be suitable to reduce/avoid minimal model failures and to extract correctly, and in full, all information, such as intersubject variability, from the experimental data. The use of population analysis is also reported for the first time for subjects with Type II diabetes.
METHODS

Subjects and experimental protocol
Subjects with newly presenting Type II diabetes according to World Health Organization criteria participated in the study [n = 65; 53 males, 12 females; age 54 + − 9 (33-71) years; body mass index 30.4 + − 5.2 (20.9-43.4) kg/ m 2 ; mean + − SD (range)]. The study was approved by Bro Taf Local Research Ethics Committee, Cardiff, U.K., and all subjects gave written informed consent.
The subjects were admitted to the Diabetes Research Unit, Llandough Hospital, Penarth, U.K. following an overnight 12 h fast and underwent IVGTT consisting of a 0.3 g of glucose bolus/kg of body weight given at time zero over 2 min, followed by 0.05 unit of insulin/kg of body weight (Actrapid; Novo Nordisk, Denmark) at 20 min. Blood was taken via an indwelling intravenous cannula, which was inserted into the antecubital fossa vein and connected via a three-way tap to a slow running saline infusion to maintain the patency of the vein. Samples were taken at − 30, − 15, 0, 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 16, 19, 22, 23, 24, 25, 27, 30, 40, 50, 60, 70, 80, 90 , 100, 120, 150 and 180 min for measurement of plasma glucose and insulin.
Assays
Glucose was assayed using glucose oxidase method [YSI 2300, Yellow Springs Analyzer; Yellow Springs Instruments, Yellow Springs, OH, U.S.A.; intra-assay coefficient of variation (CV) < 2 %]. Insulin was assayed using immunoassay utilizing monoclonal antibodies (Dako Diagnostics, Ely, Cambs., U.K.; intra-assay CV < 5 %).
Data analysis
Minimal model of glucose tolerance during IVGTT
The minimal model defines S I (ability of insulin to enhance the net glucose disappearance from plasma) and individual S G (ability of glucose to promote its own disposal) [10, 11] and is described by two differential equations
where g t is the plasma concentration of glucose, i t is the plasma insulin concentration, x t is a variable associated with the remote insulin compartment, g b is the (end-experimental) basal glucose concentration, i b is the (end-experimental) basal insulin concentration, D is the amount of exogenous glucose injected at time 0, p 1 , p 2 and p 3 are model parameters and V is the volume of the distribution. S I is given as the ratio of p 3 /p 2 , and S G is given by p 1 . Glucose concentrations from 0-5 min were excluded from the parameter estimation with all parameter estimation approaches.
Bayesian hierarchical analysis
An illustrative outline of the Bayesian analysis is shown in Figure 1 . The analysis included the development of a hierarchical model with individual and population parameters.
Within the context of the Bayesian analysis, prior distributions of parameters were specified. We adopted 'vague' (non-informative) prior distributions representing the lack of prior information about parameter values. The prior distributions were 'updated' from glucose and insulin measurements adopting the Bayes theorem giving the individual posterior distributions. These posterior distributions 'correspond' to point estimates derived
Figure 1 Bayesian hierarchical analysis of the minimal model indices
Individual S I and S G values were estimated in parallel with the population characteristics (the mean and S.D.). All indices were treated as random variables and the estimation involves determining their probability density functions. Log-normal population distribution is assumed to reflect that S I and S G can attain only non-negative values. The Bayesian hierarchical analysis facilitates 'information' flow between individuals (individual estimate depends on the measured glucose and insulin data and also on the population mean and S.D., which is, in turn, influenced by other individual values) and also results in estimates with higher precision contributing with a greater weight to the population characteristics.
by the non-linear regression analysis in the sense that they contain the result of the estimation procedure [12] . However, the posterior distributions are informationrich and can be used, for example, to determine directly the precision of the estimate using a measure of dispersion, such as the 95 % CrI or the CV of the posterior distribution.
The Bayesian analysis demands the form of underlying distributions to be specified. We assumed that individual parameters such as S I and S G are log-normally distributed, guaranteeing their non-negativity, and thus the physiological plausibility of associated 95 % CrI. We denote S I BAY and S G BAY as Bayesian estimates of S I and S G respectively.
Individual estimates of S I BAY and S G BAY were calculated as medians of the posterior distributions and the precision of the estimates as the CV of the posterior distributions. The median was chosen as it is a more robust measure than the mean (subsequent analysis indicated, however, that median and mean of individual estimates are nearly identical). Owing to the nature of the Bayesian analysis, population parameters (mean, CrI and interquartile range) are not obtained by statistical evaluations of individual results, but rather as an integral part of the Bayesian analysis. This reflects that individual parameters estimated with higher precision contribute with 'greater' weight to the population characteristics.
For the calculations, we employed the public domain WinBUGS program [13] extended by a purpose-made module implementing the numerical solution of eqns (1) and (2) . The WinBUGS program adopted the MetropolisHastings algorithm [14] to calculate a single chain with 26 000 samples (with thinning of four), from which the first 6000 samples were discarded and the remaining 20 000 samples were used in a further analysis. Convergence criteria of the chain were tested using the Geweke method and the Raftery-Lewis method implemented in the CODA package [15] . The calculations were performed on a computer running the Microsoft Windows NT operating system with 512 MB RAM and a single 650 MHz Pentium processor. The generation of the chain with 26 000 samples took approx. 12 h.
Further details about the Bayesian hierarchical analysis are given in the Appendix.
Standard two-stage minimal model analysis
The two-stage minimal model analysis is the traditional method to determine population values. In the first stage, a weighted non-linear regression analysis was employed to estimate the model parameters and, specifically, S I and S G were denoted S I NLR and S G NLR respectively. The weight was defined as the reciprocal of the variance of the measurement error [16] . The CV of the measurement error of unlabelled glucose was assumed at the level of 1.5 %. The parameter estimation procedure provided the precision of a parameter estimate expressed as the CV of the parameter estimate from the Fisher information matrix [16] .
In the second stage, the population (geometric) mean and 95 % CI of S I NLR and S G NLR was calculated.
Statistical analysis
Values are reported as means (95 % CI for two-stage analysis or CrI for the Bayesian hierarchical analysis).
The results of the Bayesian analysis are reported as medians of the posterior density functions, reflecting that medians are more robust than means. SPSS for Windows V9.0 (SPSS Inc., Chicago, IL, U.S.A.) was used to carry out statistical calculations associated with the two-stage analysis. S I and S G estimated by the two methods were correlated using Spearman correlation (r s ) to account for skewed distributions. The correlation coefficients for 20:80 % centiles of S I were compared using Fisher z transformation [17] .
RESULTS
Plasma glucose and plasma insulin
Plasma insulin and glucose data are shown in Figure 2 .
Bayesian hierarchical analysis
The Bayesian analysis provided estimates of S I BAY and S G BAY in all subjects with good precision [16 % (3-59 %) and 14 % (7-18 %) respectively; median (range)]. Precision of individual estimates of p 2 BAY and V BAY was also good [19 % (8 %-41 %) and 4 % (3 %-7 %)]. Population characteristics of S I BAY , S G BAY , p 2 BAY and V BAY are given in Table 1 .
The posterior density of the population mean of S I BAY and S G BAY is shown in Figure 3 . The posterior density of individual values of S I BAY and S G BAY is also shown (obtained by sampling from the population posterior distribution, see Appendix for details).
The population mean densities in Figure 3 (thick lines) are narrow and nearly symmetrical. This means that the population mean for the two parameters is well defined and its CrIs are symmetrical around the mean. The individual density of S I in Figure 3 (upper panel, thin line) with a small inter-subject variability (nearly no subjects below 0.7 × 10 −2 min −1 or above 2.7 × 10 −2 min −1 ).
Standard two-stage analysis
The non-linear regression analysis successfully estimated S I NLR in all but four subjects (a 6 % failure rate) when the CV of the parameter estimate was 150 %. 
Comparison of the standard two-stage and Bayesian hierarchical analysis
The non-linear regression analysis failed to estimate S I with precision in subjects #5, #6, #31 and #44, whereas the Bayesian hierarchical analysis returned S I in these four subjects with acceptable precision (range of CV 46-59 %). These four S I values were in the lower quartile and were 1st, 4th, 9th and 14th lowest among the studied group at 0.21, 0.28, 0.39, and 0.50 × 10
. Their posterior density function is shown in Figure 4 . Subjects #5, #6 and #44 had the lowest, and subject #31 had the 7th lowest precision, as determined by the Bayesian hierarchical analysis (59 %, 58 %, 53 % and 46 % respectively). Otherwise, there was no apparent difference in the shape of the posterior density functions, which would provide a further insight into the failure of the non-linear regression analysis. This suggests that the non-linear regression analysis tends to fail in subjects with low and poorly defined S I .
Individual S I values estimated by the two methods were highly correlated (r S = 0.98; P < 0.001). However, the correlation in the lower 20 % centile of the S I range was significantly lower than the correlation in the upper 80 % centile (r S = 0.71 compared with r S = 0.99; P < 0.001), supporting further the notion that the nonlinear regression analysis has difficulties at low-insulin sensitivities. The non-linear regression tended to provide slightly higher S I estimates, as shown in Figure 5 . The difference was not considered clinically significant. The inset in the upper panel of Figure 5 highlights the comparison at lower values of S I .
The precision of individual S I estimates provided by the two methods was highly correlated (r S = 0.82; P < 0.001) and was similar in extent, although the Bayesian hierarchical analysis gave a tighter range. This is most probably due to the hierarchical nature of the analysis, i.e. borrowing of strength across individuals.
A different picture emerged when considering S G . Estimates provided by the two methods were still highly correlated (r S = 0.77; P < 0.001), but were not proportional (the unity line is different from a projected regression line; Figure 5 ). The non-linear regression gave a wider range of S G . There were large differences in several subjects and these were generally in estimates with low precision, as returned by the non-linear regression analysis ( Figure 5 ).
The precision of S G was not correlated between the two methods (r S = 0.12; P = not significant). The Bayesian hierarchical analysis returned estimates with identical precision as judged by the median, but with a tighter dispersion (2 % compared with 16 % S.D. of the precision), explained again by the ability of the Bayesian hierarchical analysis to borrow of strength across individuals.
The comparison of population characteristics is shown in Table 1 . In the case of the Bayesian analysis, the mean and CrI were directly extracted from the posterior density of the population mean and the interquartile range was obtained from a simulated posterior distribution of an individual parameter (Figure 3 ). In the case of the non-linear regression analysis, the characteristics correspond to the log-normal distribution of the parameter. There was no statistical difference between the two methods as demonstrated by overlapping CIs and CrIs. However,
Figure 4 Posterior density function of individual S I derived by Bayesian hierarchical analysis in subjects where non-linear regression analysis failed
Subjects #5, #6, #31 and #44 were used.
the Bayesian hierarchical analysis gave tighter estimates, as indicated by a smaller interquartile range for both S I and S G by 20 % and 15 % respectively.
DISCUSSION
The present study demonstrates that the Bayesian hierarchical analysis is an appealing method to estimate population and individual S I and S G with the minimal model analysis of IVGTT. The appeal is due to the reliability of the parameter estimation process (100 % success rate) underpinned by coherent theoretical foundations of the methodology.
The Bayesian hierarchical analysis avoids minimal model failures, which occur in subjects that combine low S I and low precision of its estimate, as shown in the present study. We experienced a modest failure rate of 6 % with the use of insulin modification and the standard non-linear regression analysis. The failure rate is expected to increase with the use of protocols without insulin or tolbutamide modification, as the insulin stimulus is invariably smaller and inadequate to estimate S I in the insulin-resistant state. In such studies, the Bayesian hierarchical analysis will have a greater impact and will avoid a potential bias toward a higher estimate of population S I (this bias was not statistically significant in the present study).
An independent estimate of S I is not available. Ideally, our present results should be confirmed by, for example, clamp studies. However, the results are consistent as the failures occur in subjects with low sensitivity. The reliability of the Bayesian hierarchical analysis is inferred from an excellent correlation with the non-linear regression analysis.
The Bayesian hierarchical approach is computationally demanding and cumbersome to deal with changes in the data set, i.e. adding a new subject or eliminating an outlier requires a completely new run. This should not be a problem in laboratory (non-epidemiological) studies due to shorter runs, but particular care needs to be exercised when dealing with data sets of our size or larger. In this situation, it becomes essential to prepare data well to avoid wasteful long runs.
The individual Bayesian method [8] is an alternative approach, which is more flexible (but overall the computation complexity is similar) than the Bayesian population approach and avoids 'failures' using a 'somewhat' informative prior distribution. The Bayesian individual analysis specifies that S I above a certain fixed threshold is less probable. The Bayesian population analysis avoids this assumption. The distribution of S I within the studied population co-determines S I within a particular individual. We believe that the latter is more appropriate as it exploits information present in a particular subject group. The Bayesian hierarchical analysis adopts two sets of assumptions. First, the type of the underlying distributions needs to be chosen. Secondly, prior distributions have to be specified. The type of underlying distributions for parameters, i.e. the log-normal distribution, adopted by the present study is both compatible with results of the standard two-stage analysis (results not shown) and physiologically feasible. It provides positive estimates of the parameters and also positive CrIs. We adopted a vague non-informative prior distribution, which was sufficient to obtain well-defined population and individual posteriors. This contrasts with the Bayesian 'individual' analysis [8] , which required a somewhat informative prior distribution for S I to avoid large CrIs associated with S I , suggesting that additional information has to be provided for the individual Bayesian analysis to compensate for the lack of information about the underlying population characteristics.
The Bayesian hierarchical analysis is 'expensive' in terms of the computational time. The calculations took approx. 12 h on a mid-specification computer. This compares less favourably with the non-linear regression analysis with several seconds needed to run a single subject. However, compared with the overall time-scale of epidemiological studies, which normally take months to complete, the increased computational time is negligible. The appeal of the Bayesian approach originates from its ability to provide theoretically coherent plausible individual, population and precision estimates. However, care needs to be taken during data preparation to avoid wasteful runs.
An alternative, computationally faster, populationbased approach is the iterative two-stage analysis, which has been shown to improve precision of minimal model parameters with reduced sampling using unmodified IVGTT in healthy subjects [9] . The method is computationally attractive and implements an empirical Bayesian hierarchical estimator. A full comparison using a common data set of the Bayesian hierarchical analysis and the iterative two-stage method is warranted to explore whether simplifications made by the latter method influence results at low S I as observed with the standard two-stage analysis.
Our analysis of a mid-size group of newly presenting Type II diabetes subjects gave a modest 6 % failure rate of the non-linear regression analysis. This small failure rate could be attributed to frequent sampling, a relatively high dose of insulin (0.05 unit/kg of body weight) and a high accuracy of analytical techniques. The failures occurred in subjects with very low S I . Any relaxation of the conditions given above is likely to give a higher failure rate, most likely in subjects with low S I , distorting the population characteristics.
We have evaluated further the Bayesian hierarchical analysis with a small number of subjects when the population distribution is likely to be estimated with a lower confidence. We have carried out an analysis on a subset containing nine subjects, including two subjects failing S I estimation, with the non-linear regression analysis. The results demonstrated that Bayesian hierarchical analysis is suitable for smaller subject groups too. All nine subjects provided well-defined S G estimates (CV of parameter estimates < 25 %) and acceptable S I estimates (CV < 90 %; higher CV values for lower S I ). Individual S I estimates were highly correlated among the full set and the subset (r = 0.99; P < 0.001) without introducing bias (P = not significant; paired Student's t test). A similarly high correlation (r = 0.98; P < 0.001) and a lack of bias (P = not significant) were observed for S G .
Population analysis with the minimal model of the tolbutamide-modified IVGTT has been reported using the non-linear mixed effect model implemented within the NONMEM package for healthy subjects [18] . The authors reported improved precision of population estimates compatible with our present results, but the population variability was very similar between the standard two-stage analysis and the NONMEM results. The authors [18] did not report NONMEM-derived individual estimates of S I and S G , although these can be in principle obtained with the so-called 'post-hoc' option.
Population kinetics methods have become essential to study drug pharmacokinetics. The knowledge of population variability facilitates the design of efficacious and safe dosing schemes. The size of population studies normally prevents a complex experimental set-up and only limited number of samples per subject can be taken; however, this does not prevent the use of population approaches.
The physiological modelling field is following the trend. The main appeal of the present application is due to the avoidance of estimation failures. However, as the computational and conceptual complexity of Bayesian methods is considerable, the development of more userfriendly tools is needed to support wider deployment.
The simplest methods to assess S I , such as HOMA [19] and QUICKI [20] , rely on fasting glucose and insulin. These techniques estimate so-called basal S I , whereas most techniques measure stimulated S I [21] . Basal S I primarily reflects sensitivity of endogenous glucose production, whereas stimulated sensitivity also contains the sensitivity of glucose disposal [22] . When stimulated S I is of interest, the Bayesian hierarchical analysis is a method to be considered, especially in insulin-resistant subjects with or without Type II diabetes.
In conclusion, Bayesian hierarchical analysis is an appealing method to estimate population and individual S I and S G with the minimal model of the insulin-modified IVGTT. The method avoids parameter estimation failures and gives a smaller unbiased estimate of the population dispersion for both S I and S G .
APPENDIX Comments on Bayesian analysis
The Bayesian analysis is underpinned by a formula derived from the Bayes theorem
which states that the probability p( P | c) of parameters P given measurements c is proportional to the product of the so-called likelihood p(c | P), and the prior probability of P, p(P). In our case, c represents a vector of plasma glucose measurements, and P represents a vector of parameters. The vector P can be conveniently divided into three components P = {ξ , µ, }: ξ contains individual parameters (e.g. individual S I and S G ), µ contains population means (e.g. mean S I and mean S G ) and contains population variance-covariance (e.g. the intersubject variability of S I and S G ). The probability p( P | c) represents the posterior probability as it denotes probability of P after we observed c. Assuming, for the sake of simplicity, that P includes just one parameter, say S I for one subject, p( P | c) defines a probability density function, which assigns probability for all possible values of S I .
The calculation of posterior probability is the objective of the Bayesian analysis. It should be stressed that the posterior probability is 'richer' than the estimate provided by the non-linear regression analysis. For example, the Bayesian analysis returns a value (probability) for each value of S I , whereas non-linear regression analysis returns just one value, the point estimate of S I . The Bayesian analysis enables the assessment of multimodal solutions (there might be two or more parameter values that provide a good fit to the data).
Another method, the maximum a posteriori Bayesian analysis works in a similar way to the non-linear regression analysis and returns a value at which the posterior probability attains its maximum value.
The Bayesian analysis requires the provision of the prior probability p(P), i.e. probability of P prior to having any observation. Two conceptual types of prior probability can be considered, either informed or vague. The former specifies that certain values are more likely than others, the latter that all values occur with a similar probability. The property of the former is that we bring into the calculations our informed prior knowledge, but the drawback is that the prior knowledge might be too strong and influence the results, possibly too much. The latter avoids the use of informed knowledge (even if available) and makes the Bayesian analysis driven by the observations.
Comments on hierarchical analysis
As described above, the vector P includes individual parameters (ξ ) and population parameters (µ and ). Mixing up individual and population parameters contributes to the difficulties with the specification and solution of Bayesian problems.
The hierarchical analysis separates levels and simplifies the specification of the problem and the calculation of the solution. The first level describes how observations are obtained from individual parameters, i.e. the likelihood p(c | ξ ) is defined from the minimal model equations. The second stage describes how individual parameters are obtained (drawn from) population parameters, i.e. the likelihood p(ξ | µ, ) is defined using the equation representing the chosen population probability distribution such as the log-normal distribution. The third and final stage describes how the population parameters are drawn from prior distributions.
Technical details of the Bayesian hierarchical analysis of the minimal model
A Bayesian framework for modelling the time-varying glucose profile during IVGTT and inter-individual variability requires a three-stage hierarchical model. At the first stage, glucose values g ij in subject i at time t j were obtained as the solution to eqns 1 and 2
where p 1i , p 2i S Ii and V i are parameters of subject i, ε ij is the random term representing the multiplicative measurement error and the model specification error and other unaccounted variability. The random term ε ij is drawn from a normal distribution with a zero mean and an unknown variance σ 2 . Our earlier investigations (results not shown) suggested that reparameterization with p 1i , p 2i , S Ii and V i is preferable (converges faster) to the original parameterization p 1i , p 2i , p 3i and V i , where
The second stage is characterized by making assumptions about individual parameters. In particular, we assumed that the individual parameters are drawn from a multivariate log-normal distribution guaranteeing nonnegativity of parameters
where µ is an unknown population mean vector, is an unknown covariance matrix and LNORMAL is the log-normal distribution.
At the third stage, prior distributions for population parameters µ, , and σ 2 were specified. These prior distributions were vague representing 'lack' of prior knowledge These prior distributions specify virtually 'flat' distributions, i.e. they indicate that all values occur with nearly the same probability. In principle, informative prior distributions could be used as there is a wealth of information about parameters of the minimal model in various populations. However, in the present study, we limited the use of such information in order to allow the experimental data to drive the estimation process, although information is contained in the form of chosen distribution, e.g. log-normal for individual parameters.
A general discussion about the form of vague prior distribution can be found in the literature, for example Gamerman [23] .
Eqn (6) implements the common assumption that population parameters are not correlated, but allows the posterior estimates to demonstrate correlation.
The main purpose of the Bayesian inference [24] is to determine the posterior probability of unknown quantities such as individual parameters p 1i , p 2i , S Ii and V i and population parameters µ, and σ 2 . For our model, this cannot be achieved by direct (analytical) computation. Instead, sampling techniques such as the Markov chain Monte Carlo method [6] have to be used. These sampling techniques provide a large sample of the posterior distributions normally running into thousands to tens of thousands of samples.
The posterior distributions were summarized by the median, the mean and 95 % CrI respectively.
The posterior distribution of the parameters µ and was used to generate 20 000 samples of individual parameters, which determined the individual posterior distributions (thin line) in Figure 3 .
